Meixin Teng
Papers
1
Total Citations
5
H-Index
1
About
Dr. Meixin Teng is a pioneering thoracic surgeon whose research focuses on optimizing surgical outcomes for lung cancer patients, particularly through the comparative analysis of robotic-assisted thoracic surgery (RATS) and video-assisted thoracoscopic surgery (VATS). Their most cited work, a 2024 study examining perioperative outcomes in non-small cell lung cancer (NSCLC) patients following neoadjuvant chemoimmunotherapy, has already garnered 5 citations, reflecting its timely impact on a rapidly evolving clinical landscape. Dr. Teng’s major contribution lies in addressing a critical knowledge gap: how advanced surgical techniques perform in patients who have undergone pre-surgical chemoimmunotherapy—a growing standard of care. By systematically comparing RATS and VATS, their research provides evidence-based guidance for surgeons navigating complex, immunologically primed cases. This work not only enhances understanding of postoperative recovery, complication rates, and oncologic efficacy but also informs personalized surgical decision-making. Dr. Teng’s dedication to advancing minimally invasive thoracic oncology underscores their role as a key voice in shaping modern lung cancer treatment paradigms, bridging cutting-edge technology with patient-centered outcomes.
Research Focus
Key Achievements
Top Papers
- 1